Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $987.00K in the quarter ending September 30, 2024, with 135.56% growth. This brings the company's revenue in the last twelve months to $2.65M, down -26.49% year-over-year. In the year 2023, Orchestra BioMed Holdings had annual revenue of $2.76M, down -21.88%.

• Revenue (ttm): $2.65M
• Revenue Growth: -26.49%
• P/S Ratio: 64.36
• Revenue / Employee: $47,268
• Employees: 56
• Market Cap: 179.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.76M	-773.00K	-21.88%
Dec 31, 2022	3.53M	4.32M	-551.79%
Dec 31, 2021	-782.00K	-6.49M	-113.71%
Dec 31, 2020	5.70M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.